SYSTIMMUNE
Updates & Highlights
SystImmune, Inc. to Present New iza-bren (izalontamab brengitecan) Data in Extensive Stage Small Cell Lung Cancer at ELCC 2026
SystImmune, Inc. to Present New iza-bren (izalontamab brengitecan) Data in Extensive Stage Small Cell Lung Cancer at ...
PR Newswire · 3 days ago
FDA grants breakthrough status to Bristol drug with SystImmune for lung cancer
FDA grants breakthrough status to Bristol drug with SystImmune for lung cancer - Read more on MSN
MSN · 1 day ago
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan ...
Business Wire · 24 days ago
Recent Openings
View all 1 jobsCulture & Mission
Systimmune is building innovative AI solutions with a focus on collaboration and excellence. Join a team of talented engineers working on cutting-edge technology.
Office-Based
Benefits & Perks
🏥
Health Insurance
Medical, dental & vision
📚
Learning Budget
Professional development
🏖️
Generous PTO
Paid time off
💰
Competitive Salary
Market-rate compensation
📈
Equity/Stock Options
Ownership in the company
🏠
Remote Work
Work from anywhere flexibility
Tech Stack
Ai Ai Engineer Machine Learning
Core Values
🎯
Innovation
Pushing boundaries in AI/ML technology
🤝
Collaboration
Working together to achieve more
⚡
Excellence
Striving for the highest quality
🌍
Impact
Making a difference in the world
Office Locations
Redmond, WA, US
Redmond
US
Team
Team information coming soon